Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Delphin

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
The Journal of Infection|July 8, 2026
Evidence for a relationship between concentrations of nucleos/tide analogue agents and treatment outcome in chronic hepatitis B infection: A systematic reviewGloria Sukali, Motswedi Anderson, Khadija Said Mohammed, et al.
Molecular Therapy. Methods & Clinical Development|September 11, 2023
Modifying immune responses to adeno-associated virus vectors by capsid engineeringMartin Bentler, Romain Hardet, Moritz Ertelt, et al.
Sexually Transmitted Infections|June 24, 2024
Multiple risk factors for persistent HBV viraemia in an adult receiving nucleos/tide analogue therapySheila Lumley, Maeve Barlow, Khadija Said, et al.
Public Health|May 31, 2026
Global inequities in hepatitis B and C genomic surveillance revealed through an interactive data integration dashboardDerek Tshiabuila, Vagner Fonseca, Danilo de Castro Silva, et al.
Journal of Virus Eradication|July 10, 2024
Community dialogue to enhance understanding of beliefs, behaviours and barriers to care for people living with liver disease and HBV infection in KwaZulu Natal, South AfricaBusangani Ngwenya, Motswedi Anderson, Nondumiso Mpanza, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infectionMarion Delphin, Khadija Said Mohammed, Louise O Downs, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 11, 2024
A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovirSheila F Lumley, Marion Delphin, Jolynne F Mokaya, et al.
Journal of Hepatology|July 27, 2019
Hepatitis B virus-induced modulation of liver macrophage function promotes hepatocyte infectionSuzanne Faure-Dupuy, Marion Delphin, Ludovic Aillot, et al.
Cancer Letters|December 16, 2019
Cisplatin unleashes Toll-like receptor 3-mediated apoptosis through the downregulation of c-FLIP in malignant mesotheliomaBéatrice Vanbervliet-Defrance, Tiphaine Delaunay, Thomas Daunizeau, et al.
STAR Protocols|October 5, 2024
Protocol for isolating CD163<sup>+</sup> Kupffer cells from human liver resectionsArmando Andres Roca Suarez, Marie-Laure Plissonnier, Maud Michelet, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
The Journal of Infection|July 8, 2026
Evidence for a relationship between concentrations of nucleos/tide analogue agents and treatment outcome in chronic hepatitis B infection: A systematic reviewGloria Sukali, Motswedi Anderson, Khadija Said Mohammed, et al.
Molecular Therapy. Methods & Clinical Development|September 11, 2023
Modifying immune responses to adeno-associated virus vectors by capsid engineeringMartin Bentler, Romain Hardet, Moritz Ertelt, et al.
Sexually Transmitted Infections|June 24, 2024
Multiple risk factors for persistent HBV viraemia in an adult receiving nucleos/tide analogue therapySheila Lumley, Maeve Barlow, Khadija Said, et al.
Public Health|May 31, 2026
Global inequities in hepatitis B and C genomic surveillance revealed through an interactive data integration dashboardDerek Tshiabuila, Vagner Fonseca, Danilo de Castro Silva, et al.
Journal of Virus Eradication|July 10, 2024
Community dialogue to enhance understanding of beliefs, behaviours and barriers to care for people living with liver disease and HBV infection in KwaZulu Natal, South AfricaBusangani Ngwenya, Motswedi Anderson, Nondumiso Mpanza, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infectionMarion Delphin, Khadija Said Mohammed, Louise O Downs, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 11, 2024
A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovirSheila F Lumley, Marion Delphin, Jolynne F Mokaya, et al.
Journal of Hepatology|July 27, 2019
Hepatitis B virus-induced modulation of liver macrophage function promotes hepatocyte infectionSuzanne Faure-Dupuy, Marion Delphin, Ludovic Aillot, et al.
Cancer Letters|December 16, 2019
Cisplatin unleashes Toll-like receptor 3-mediated apoptosis through the downregulation of c-FLIP in malignant mesotheliomaBéatrice Vanbervliet-Defrance, Tiphaine Delaunay, Thomas Daunizeau, et al.
STAR Protocols|October 5, 2024
Protocol for isolating CD163<sup>+</sup> Kupffer cells from human liver resectionsArmando Andres Roca Suarez, Marie-Laure Plissonnier, Maud Michelet, et al.
Pageof 3